"Experts Skeptical of Claim About AIDS Treatment" CDC Daily UpdateImportant note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




"Experts Skeptical of Claim About AIDS Treatment"

Washington Post (12/20/89), P. A4
Okie, Susan


Abstract: AIDS experts are reserving judgement on the implications of a research team's claim that it eliminated HIV from the body of an infected patient using high doses of AZT, radiation therapy, chemotherapy, and bone marrow transportation. National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci said the story was "blown of proportion" by press reports. Jerome Groopman of Harvard Medical School said, "We and others are planning on doing it." However, he cautioned, "People shouldn't jump to think this is a generalizable therapy." Many AIDS patients, Groopman said, "would not be likely to survive a transplant or don't have a compatible donor." Researchers from the Johns Hopkins University Medical Center reported that the technique, developed to treat lymphoma and leukemia, rid a 41-year-old AIDS patient's blood of HIV within 32 days after the transplant. However, a recurrence of lymphoma killed the man a short time later. Up to 70 percent of non-AIDS patients who undergo the therapy die of complications from the procedure or a recurrence of cancer.


891220
AD892683


Copyright © 1989 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.